Clinical Trial Update: Secondary Prevention of Cardiovascular Disease in the Elderly Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating secondary prevention of cardiovascular disease in the elderly has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Myocardial Infarction

Snippet

Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | Conditions: Myocardial Infarction, Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-05-23